Q4

Thyrocare Technologies Ltd

THYROCAREFY2523 Apr 2025

Revenue+12.8%

Net Profit+13.8%

OPM30.83%

P&L

Quarterly Consolidated

Revenue

+12.8%187.16

Expenditure

+1.5%143.93

Net Profit

+13.8%21.57

NPM 11.25%+0.0%EPS ₹4.17+16.5%

vs Q3 FY25

Informational and educational content only. Not investment advice.